Sam Gautam

WF GS LCat LBS | M&A / PE Healthcare, Tech, Consumer

London Area, United Kingdom

About

CFA (2017-2020) Charter Holder | CAIA London | Singapore Investment Banking | Growth equity | Private Equity I am a highly driven finance professional interested in opportunities for growth in private equity and investment banking. I am good at investment analysis, financial modelling, finance, and strategy with strong analytical, quantitative, interpersonal, and organisational skills.

Experience

  • Wells Fargo (2 yrs 10 mos)
    • Vice President
      Feb 2025 - Present · 1 yr 5 mos

      UK and EMEA M&A and public takeover coverage across all sectors (healthcare, TMT, consumer, industrials, real estate, energy) with a focus on UK Takeover Code

    • Investment Banking Sr. Associate
      Sep 2023 - Feb 2025 · 1 yr 6 mos

      UK and EMEA M&A and public takeover coverage across all sectors (healthcare, TMT, consumer, industrials, real estate, energy) with a focus on UK Takeover Code

  • Investment Banking Associate at Goldman Sachs
    Nov 2020 - Present · 5 yrs 8 mos

    EMEA Consumer Retail Healthcare (CRH) Investment Banking Division (IBD) - €1b+ take-private (P2P/public to private) buyout transaction in the consumer (food & beverage) sector in Europe backed by a leading family office sponsor - Buyside advisory on potential acquisition of Reebok from Adidas - Sellside advisory on potential disposal of Boot's (pharmacy retail business in UK) by Walgreens Boots Alliance - Potential IPO of leading European online ecommerce business (postponed) - Potential IPO of leading global pharmacy retail business (postponed) - Client coverage including some of the leading global brands from Europe in the consumer packaged goods and consumer sectors

  • Investment Banking Associate at Harris Williams
    Jul 2022 - Aug 2023 · 1 yr 2 mos

    M&A Advisory for mid-market focusing on the healthcare and life sciences sectors (outsourced pharma services including CDMOs, CROs, MedTech CMOs, medical products, MedTech, providers, consumer healthcare products, HCIT and others) - €1.3bn sale of PharmaLex, a leading CRO/regulatory services provider to global pharma, by Auctus Capital Partners to AmeriSource Bergen

  • Private Equity Intern at L Catterton
    Sep 2020 - Nov 2020 · 3 mos

    With approximately $20 billion of equity capital across seven fund strategies in 17 offices globally, L Catterton is the largest consumer-focused private equity firm in the world. L Catterton's team of nearly 200 investment and operating professionals partners with management teams around the world to implement strategic plans to foster growth, leveraging deep category insight, operational excellence, and a broad partnership network. Since 1989, the firm has made over 200 investments in leading consumer brands. L Catterton was formed through the partnership of Catterton, LVMH, and Groupe Arnault. For more information about L Catterton, please visit www.lcatterton.com

  • Investment Banking Summer Associate at Goldman Sachs
    Jul 2020 - Aug 2020 · 2 mos

    - $1.5b+ take-private (P2P/public to private) buyout transaction in the retail sector in UK, Ireland, United States backed by a leading global PE sponsor - $0.5b+ add-on/bolt-on acquisition for a buy-and-build/roll-up platform backed by a leading global PE sponsor in the healthcare/pharma sector in Europe - Client coverage including some of the leading global brands from Europe in the consumer packaged goods and consumer sectors